Theophylline-estrogen interaction in the rat uterus: role of the ovary.
Uterine edema induced by 0.1 microgram/100 g body wt of estradiol further increases in the presence of theophylline. Theophylline alone or in the presence of 0.001, 0.01, 0.1, and 1 microgram/100 g body wt of estradiol increases uterine RNA and protein content 6 h after its administration, as compared with the same doses of estradiol alone. Both phenomena disappear in the ovariectomized immature rat, suggesting that theophylline potentiates the action of gonadotropins, increasing the synthesis of endogenous ovarian estrogens by the immature ovary. Theophylline decreases the number of eosinophils in the blood and concurrently decreases estrogen-induced uterine eosinophilia at doses of 0.01, 0.1, 1, 10, and 30 micrograms/100 g body wt of estradiol. Estrogen binding by uterine eosinophils in vitro increases in the presence of theophylline. This effect of theophylline could also explain the increase in vivo in estrogen-induced uterine edema.
D000818:Animals; D004359:Drug Therapy, Combination; D004487:Edema / Q000139:chemically induced / Q000378:metabolism*; D004804:Eosinophils / Q000166:cytology; D004958:Estradiol / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D007958:Leukocyte Count; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D051381:Rats; D013806:Theophylline / Q000494:pharmacology*; D014591:Uterine Diseases / Q000139:chemically induced / Q000378:metabolism*; D014599:Uterus / Q000378:metabolism*
D011506:Proteins; D004958:Estradiol; D012313:RNA; D013806:Theophylline